- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 108.28M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $30.36M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $24.57M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $21.51M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $31.6M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $54.03M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $64.77M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $108.79M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $125.95M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $198.09M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $220.33M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 71.07M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $135K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$20.82M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $142.01M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $157.18M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.24 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.24 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $6.84M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $9.85M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$16.94M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$18.93M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $809K |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.4M |